Company facts
- Headquarters
- King of Prussia, Pennsylvania
- Most recent report
- 10-Q, filed Nov 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 352915
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 66
News 8 of 169
Prospectuses and Registrations 8 of 20
- S-8 Registration statement for an employee plan Aug 18, 2026
- 424B5 Prospectus supplement for an offering Aug 13, 2026
- FWP Free writing prospectus Aug 12, 2026
- 424B5 Prospectus supplement for an offering Aug 10, 2026
- 424B5 Prospectus supplement for an offering Sep 19, 2024
- FWP Free writing prospectus Sep 18, 2024
- 424B5 Prospectus supplement for an offering Sep 16, 2024
- S-3ASR Automatic shelf registration Sep 16, 2024
Proxies 8 of 37
- DEFA14A Extra proxy material Apr 9, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2026
- DEFA14A Extra proxy material Apr 3, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2025
- DEFA14A Extra proxy material Apr 4, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2024
- DEFA14A Extra proxy material Apr 6, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 6, 2023
Ownership 8 of 663
- SCHEDULE 13G Large holder reported a passive stake Oct 19, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 8, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- 4 Insider reported a trade May 29, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
Other 8 of 46
- POSASR Aug 7, 2026
- ARS Annual report sent to shareholders Apr 9, 2026
- ARS Annual report sent to shareholders Apr 3, 2025
- ARS Annual report sent to shareholders Apr 4, 2024
- ARS Annual report sent to shareholders Apr 6, 2023
- EFFECT Notice that a registration became effective Nov 23, 2022
- CORRESP Reply to SEC staff Nov 21, 2022
- UPLOAD Comment letter from SEC staff Nov 17, 2022
What to read: Sep 2026 10-Q
SECSift found 5 of 10 sections worth reading, with 0 positive, 10 notable, and 11 negative flags.
Part I
Net income fell 17% in Q3 2026; large liability accruals, litigation settlements, and a Medicare termination are material.Negative- Commercial insurance terms worsened in March 2025: exclusions for sexual molestation, higher premiums, lower aggregate limits.
- Cumberland tentative settlement drove a $26M reserve increase in Q3 2026; total self-insured liability rose to $545M from $449M at Dec 2025.
- Laurel Ridge lost Medicare/Medicaid certification; generated a $16M loss in the first nine months of 2026 vs $23M profit in FY2025.
- Provo Canyon School lost its Utah license in July 2026; both campuses agreed to voluntarily relinquish adolescent licenses.
Management's Discussion (Item 2)
Net income fell 17% QoQ; OBBBA law will cut ~$500M/yr by 2032; $820M Talkspace deal closed.Notable- Issued $600M 5.5% notes due 2031 and $500M 6.0% notes due 2036 in August 2026 to refinance $700M 1.65% notes that matured.
- Same-facility acute care income before taxes fell 5.3% in Q3 2026, while behavioral health fell 1.7%.
- Interest expense rose 46% to $56M in Q3 2026, driven by higher debt and lower capitalized interest.
- Spent $690M on open-market share repurchases in first nine months of 2026, up from $566M in same period of 2025.
- Total debt as a percentage of total capitalization rose to 43% at September 30, 2026 from 40% at December 31, 2025.
Negative- OBBBA law will reduce aggregate annual net benefit by ~$500M by 2032, starting in state fiscal year 2028.
- Net income attributable to UHS fell 17% to $309M in Q3 2026 from $373M in Q3 2025.
- Reserves for self-insured claims increased $37M in Q3 2026 and $65M YTD, due to unfavorable trends and a tentative settlement.
Legal Proceedings (Item 1)
Cross-reference to Note 6; legal proceedings often contain material contingencies.Risk Factors (Item 1A)
New $820M Talkspace acquisition risks and DC hospital restructuring with OAG review.Negative- $820M Talkspace acquisition financed with new debt; integration, provider retention, and synergy risks are now live.
- UHS assumed management and financial responsibility for new physician group CMG; operating losses may exceed expectations.
- University's financial support to UHS for DC hospitals ends after five years; losses after that hit results harder.
- Some MFA physicians did not join CMG; they may stop treating patients at UHS's DC hospitals, reducing revenue.
Unregistered Sales and Repurchases (Item 2)
Large buyback activity: $242M spent in Q3 2026, $1.4B authorization remaining.
What changed: Sep 2026 vs. Jun 2026
About 10% of UHS's Sep 2026 10-Q is new information. 63 paragraphs were added, 282 changed, and 81 removed. Below are the most important lines SECSift identified.
New
- Added Exhibit 4.2: Form of Global Note representing the 2031 Notes (included in Exhibit 4.1).
- Added Exhibit 4.3: Form of Global Note representing the 2036 Notes (included in Exhibit 4.1).
- Added Exhibit 4.4: Additional Authorized Representative Joinder Agreement dated August 20, 2026, filed as Exhibit 4.6 to Form 8-K dated August 21, 2026.
- Added Exhibits 4.5, 4.6, and 4.7: Fifth, Fourth, and Fourth Supplemental Indentures each dated October 5, 2026, governing 2030 Notes, 2026/2032 Notes, and 2029/2031/2034/2036 Notes respectively.
Changed
- Charity care fell to $233M from $348M in Q3 2026 vs Q3 2025; uninsured discounts rose to $1,105M from $716M.
- Net cash from operations rose to $1.481B from $1.290B in first nine months of 2026 vs 2025.
- Remaining repurchase authorization fell to $735.4M at September 30, 2026 from $977.6M at June 30, 2026.
- Exhibit 4.1 changed from Fourth Supplemental Indenture dated April 22, 2026 to Third Supplemental Indenture dated August 20, 2026, adding JPMorgan as collateral agent and covering 5.500% Notes due 2031 and 6.000% Notes due 2036.
- Quarter referenced changed to third quarter of 2026 from second quarter of 2026.
- University may provide potential annual financial support during first five years, subject to annual limits.
Everything here comes from Universal Health Services Inc's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 6, 2026, from the 10-Q for Sep 2026.